Browse 11 Pharmaceutical companies funded by Almi Invest. See funding amounts, founder contacts, and investment details.
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.
TIRmed Pharma develops drug candidates addressing major clinical needs.
Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic.
Empe Diagnostics develops diagnostic solutions for infectious diseases with a special focus on antimicrobial resistance.
View all companies funded by Almi Invest across every industry and funding stage.
View Full Almi Invest Portfolio